Medicamente Program National Oncologie,Hematologie,HIV-SIDA
6 suppliers awarded•102 lots awarded•€6.71M awarded
Buyer: SPITALUL JUDETEAN SATU MARE / Satu Mare, Romania
Awarded value
€6.71M
Estimated value
€54.09M
Awarded at 12% of estimated value
Award date
—
Winners
6
Lots awarded
102
Award values
Notice total
€6.71M
Sum of lot awards
€59.00M
TED notice total and lot-level values do not exactly match.
Winners
Bucuresti, ROU
€3.1M This contract
737 award notices•2,493 awarded lots•€436.65M total
Ghimbav, ROU
€199,567 This contract
663 award notices•1,838 awarded lots•€137.84M total
Bucuresti, ROU
€5,646 This contract
580 award notices•1,967 awarded lots•€329.70M total
Brasov, ROU
€3,945 This contract
589 award notices•2,505 awarded lots•€52.18M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0101 | Framework | Not specified | €4.5M | Antineoplastic agents (33652100) |
| LOT-0062 | Framework | Not specified | €3.5M | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0144 | Framework | Not specified | €2.9M | Antineoplastic agents (33652100) |
| LOT-0147 | Framework | Not specified | €2.3M | Antineoplastic agents (33652100) |
| LOT-0104 | Framework | Not specified | €2.2M | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0098 | Framework | Not specified | €1.8M | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0148 | Framework | Not specified | €1.7M | Antineoplastic agents (33652100) |
| LOT-0116 | Framework | Not specified | €1.7M | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0075 | Framework | Not specified | €1.7M | General anti-infectives for systemic use and vaccines (33651000), Antivirals for systemic use (33651400) |
| LOT-0141 | Framework | Not specified | €1.6M | Antineoplastic agents (33652100) |
| LOT-0105 | Framework | SERMEDIC S.R.L. | €1.4M | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0151 | Framework | Not specified | €1.4M | Antineoplastic agents (33652100) |
| LOT-0140 | Framework | Not specified | €1.2M | Antineoplastic agents (33652100) |
| LOT-0072 | Framework | ALLIANCE HEALTHCARE ROMÂNIA SRL | €1.1M | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0119 | Framework | Not specified | €1.1M | Antineoplastic agents (33652100) |
| LOT-0153 | Framework | Not specified | €1.0M | Antineoplastic agents (33652100) |
| LOT-0154 | Framework | Not specified | €1.0M | Antineoplastic agents (33652100) |
| LOT-0145 | Framework | Not specified | €1.0M | Antineoplastic agents (33652100) |
| LOT-0071 | Framework | Not specified | €995,745 | General anti-infectives for systemic use and vaccines (33651000), Antivirals for systemic use (33651400) |
| LOT-0068 | Framework | Not specified | €948,437 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0146 | Framework | Not specified | €866,348 | Antineoplastic agents (33652100) |
| LOT-0080 | Framework | Not specified | €847,295 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0111 | Framework | ALLIANCE HEALTHCARE ROMÂNIA SRL | €845,196 | Antineoplastic agents (33652100) |
| LOT-0125 | Framework | Not specified | €845,196 | Antineoplastic agents (33652100) |
| LOT-0067 | Framework | Not specified | €835,975 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0096 | Framework | Not specified | €834,699 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0107 | Framework | ALLIANCE HEALTHCARE ROMÂNIA SRL | €834,699 | Antineoplastic agents (33652100) |
| LOT-0127 | Framework | Not specified | €834,699 | Antineoplastic agents (33652100) |
| LOT-0103 | Framework | Not specified | €828,143 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0095 | Framework | Not specified | €802,220 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0143 | Framework | Not specified | €777,144 | Antineoplastic agents (33652100) |
| LOT-0117 | Framework | Not specified | €748,467 | Antineoplastic agents (33652100) |
| LOT-0142 | Framework | Not specified | €693,539 | Antineoplastic agents (33652100) |
| LOT-0001 | Framework | Not specified | €690,150 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0076 | Framework | Not specified | €659,834 | General anti-infectives for systemic use and vaccines (33651000), Antivirals for systemic use (33651400) |
| LOT-0064 | Framework | Not specified | €648,727 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0121 | Framework | Not specified | €648,727 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0074 | Framework | Not specified | €609,564 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0109 | Framework | Not specified | €596,212 | Antineoplastic agents (33652100) |
| LOT-0106 | Framework | Not specified | €589,774 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0152 | Framework | Not specified | €517,985 | Antineoplastic agents (33652100) |
| LOT-0123 | Framework | Not specified | €502,894 | Antineoplastic agents (33652100) |
| LOT-0132 | Framework | Not specified | €473,848 | Antineoplastic agents (33652100) |
| LOT-0061 | Framework | Not specified | €452,301 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0128 | Framework | Not specified | €439,640 | Antineoplastic agents (33652100) |
| LOT-0112 | Framework | Not specified | €421,829 | Antineoplastic agents (33652100) |
| LOT-0135 | Framework | Not specified | €394,647 | Antineoplastic agents (33652100) |
| LOT-0136 | Framework | Not specified | €390,566 | Antineoplastic agents (33652100) |
| LOT-0065 | Framework | Not specified | €323,605 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0073 | Framework | Not specified | €261,150 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0085 | Framework | DR.MAX | €255,716 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0115 | Framework | Not specified | €255,716 | Antineoplastic agents (33652100) |
| LOT-0086 | Framework | DR.MAX | €255,510 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0118 | Framework | Not specified | €255,510 | Antineoplastic agents (33652100) |
| LOT-0124 | Framework | Not specified | €248,718 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0083 | Framework | FRESENIUS KABI ROMANIA SRL | €199,567 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0149 | Framework | Not specified | €191,156 | Antineoplastic agents (33652100) |
| LOT-0134 | Framework | Not specified | €186,188 | Antineoplastic agents (33652100) |
| LOT-0108 | Framework | ALLIANCE HEALTHCARE ROMÂNIA SRL | €182,936 | Antineoplastic agents (33652100) |
| LOT-0126 | Framework | Not specified | €182,936 | Antineoplastic agents (33652100) |
| LOT-0081 | Framework | Not specified | €172,398 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0058 | Framework | Not specified | €167,555 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0057 | Framework | Not specified | €157,332 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0097 | Framework | Not specified | €150,938 | Antineoplastic agents (33652100) |
| LOT-0114 | Framework | Not specified | €144,077 | Antineoplastic agents (33652100) |
| LOT-0092 | Framework | Not specified | €142,636 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0129 | Framework | Not specified | €115,680 | Antineoplastic agents (33652100) |
| LOT-0066 | Framework | Not specified | €106,101 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0060 | Framework | Not specified | €105,940 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0113 | Framework | Not specified | €105,467 | Antineoplastic agents (33652100) |
| LOT-0138 | Framework | Not specified | €95,091 | Antineoplastic agents (33652100) |
| LOT-0102 | Framework | Not specified | €87,544 | Antineoplastic agents (33652100) |
| LOT-0094 | Framework | ALLIANCE HEALTHCARE ROMÂNIA SRL | €82,231 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0082 | Framework | Not specified | €61,315 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0055 | Framework | ALLIANCE HEALTHCARE ROMÂNIA SRL | €53,136 | General anti-infectives for systemic use and vaccines (33651000), Antivirals for systemic use (33651400) |
| LOT-0079 | Framework | Not specified | €49,288 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0093 | Framework | Not specified | €47,359 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0133 | Framework | Not specified | €46,022 | Antineoplastic agents (33652100) |
| LOT-0120 | Framework | Not specified | €45,569 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0078 | Framework | Not specified | €42,476 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0059 | Framework | Not specified | €40,383 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0110 | Framework | Not specified | €36,068 | Antineoplastic agents (33652100) |
| LOT-0084 | Framework | DR.MAX | €35,484 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0131 | Framework | Not specified | €35,484 | Antineoplastic agents (33652100) |
| LOT-0122 | Framework | Not specified | €33,586 | Antineoplastic agents (33652100) |
| LOT-0070 | Framework | Not specified | €33,437 | General anti-infectives for systemic use and vaccines (33651000), Antivirals for systemic use (33651400) |
| LOT-0087 | Framework | Not specified | €31,450 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0069 | Framework | Not specified | €24,143 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0077 | Framework | Not specified | €24,048 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0099 | Framework | Not specified | €22,556 | Antineoplastic agents (33652100) |
| LOT-0100 | Framework | Not specified | €19,594 | General anti-infectives for systemic use and vaccines (33651000) |
| LOT-0091 | Framework | Not specified | €18,228 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0155 | Framework | Not specified | €12,212 | Antineoplastic agents (33652100) |
| LOT-0088 | Framework | Not specified | €12,137 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0090 | Framework | Not specified | €11,984 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |
| LOT-0063 | Framework | Not specified | €11,216 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0137 | Framework | Not specified | €8,183 | Antineoplastic agents (33652100) |
| LOT-0056 | Framework | FARMEXIM S.A. | €5,646 | Antineoplastic agents (33652100), Antivirals for systemic use (33651400) |
| LOT-0130 | Framework | EUROPHARM HOLDING | €3,945 | Antineoplastic agents (33652100) |
| LOT-0150 | Framework | Not specified | €3,945 | Antineoplastic agents (33652100) |
| LOT-0139 | Framework | Not specified | €3,601 | Antineoplastic agents (33652100) |
| LOT-0089 | Framework | Not specified | €3,236 | Antineoplastic agents (33652100), Medicinal products for the blood and blood-forming organs (33621000) |